Skip to main content
Signal8

McErlane David

SEC insider (Form 3/4/5 filer). CIK 0001999358. Group President, Biologics at Catalent, Inc. (CTLT). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 18, 2024. Located in SOMERSET, NJ.

Companies McErlane David has filed insider reports for

  • Catalent, Inc. (CTLT): Officer, Group President, Biologics
McErlane David profile photo

McErlane David

CIK: 0001999358

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Catalent, Inc. logo
CTLT

Catalent, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Catalent, Inc. logo
    CTLT

    Catalent, Inc.

    Dec 18, 2024
    Disposition
    Direct
    36.3K shares-
  • Catalent, Inc. logo
    CTLT

    Catalent, Inc.

    Dec 18, 2024
    Award
    Direct
    11.4K shares-
  • Catalent, Inc. logo
    CTLT

    Catalent, Inc.

    Dec 18, 2024
    Disposition
    Direct
    11.4K shares-
  • Catalent, Inc. logo
    CTLT

    Catalent, Inc.

    Sep 26, 2024
    Sale
    Direct
    2K shares at avg. $59.97$120K

1-4 of 4